Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-19-000007

Chief Executive Officer gave up 34,139 shares (to pay taxes)

  • Chief Executive Officer acquired 120,100 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kim Jong Joseph · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-05 Exercise or conversion : show line 1 in the form +120,100 2,428,594 D
2019-03-05 Shares withheld for taxes : show line 2 in the form −34,139 $3.61 $123,242 2,394,455 D

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2019-03-05 Exercise or conversion : show line 3 in the form Restricted Stock Unit −120,100 120,100 240,200 D
Loading xslF345X03/wf-form4_155199657903918.xml…